PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
67 hedge funds and large institutions have $316M invested in POINT Biopharma Global Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
67
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$14.9M | |
| 2 | +$14.1M | |
| 3 | +$6.32M | |
| 4 |
Millennium Management
New York
|
+$4.49M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.35M |
Top Sellers
| 1 | -$8.61M | |
| 2 | -$4.33M | |
| 3 | -$3.32M | |
| 4 |
Goldman Sachs
New York
|
-$362K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$343K |